DrugPatentWatch Database Preview
Alimera Sciences Inc Company Profile
What is the competitive landscape for ALIMERA SCIENCES INC, and when can generic versions of ALIMERA SCIENCES INC drugs launch?
There are five US patents protecting ALIMERA SCIENCES INC drugs.
There are one hundred and sixty-five patent family members on ALIMERA SCIENCES INC drugs in twenty-six countries and one supplementary protection certificate in one country.
Summary for Alimera Sciences Inc
| International Patents: | 165 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Alimera Sciences Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | RX | Yes | Yes | 6,375,972 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | RX | Yes | Yes | 6,217,895 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | RX | Yes | Yes | 8,871,241 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Alimera Sciences Inc | ILUVIEN | fluocinolone acetonide | IMPLANT;INTRAVITREAL | 201923-001 | Sep 26, 2014 | RX | Yes | Yes | 6,548,078 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Alimera Sciences Inc
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,849,085 | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof | ➤ Try a Free Trial |
| 8,574,659 | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof | ➤ Try a Free Trial |
| 7,439,249 | Inhibitors of phosphatases | ➤ Try a Free Trial |
| 9,566,336 | In situ gelling drug delivery system | ➤ Try a Free Trial |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Alimera Sciences Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Austria | 460901 | ➤ Try a Free Trial |
| Japan | 5918195 | ➤ Try a Free Trial |
| China | 101396335 | ➤ Try a Free Trial |
| Japan | 5628467 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Alimera Sciences Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2014000063 | Germany | ➤ Try a Free Trial | PRODUCT NAME: FLUOCINOLONACETONID; NAT. REGISTRATION NO/DATE: 82809.00.00 20120720; FIRST REGISTRATION: GB PL 27813/0001 20120504 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
